QUOIN PHARMACEUTICALS LT-ADR
QNRX · NASDAQ
Updated at 2026-10-13 15:18:11
- Today's High
- $4.56
- Today’s Low
- $4.21
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $4.83
- Previous Close
- $4.36
- Volume
- 50.91K
- Market Cap
- $9.03M
- P/E Ratio
- --
- EPS
- $-12.10
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 42127 PLEASANT FOREST COURT, ASHBURN, VA, UNITED STATES, 20148-7349
- Country
- IL
- Listing Date
- 1989-11-01
- Fiscal Year End
- December
- Shares Outstanding
- 70.29M
- CIK
- 0001671502
- Website
- quoinpharma.com
Quoin Pharmaceuticals Ltd (QNRX) is an innovative biotechnology firm dedicated to developing cutting-edge therapeutics for rare diseases, addressing significant unmet medical needs in the healthcare landscape. Leveraging advanced drug delivery technologies, Quoin enhances the efficacy and safety of its treatment pipeline, thereby positioning itself for impactful clinical advancements. The company emphasizes strategic collaborations and groundbreaking research initiatives, aiming to create substantial value for both patients and investors while establishing a formidable presence in the specialty pharmaceuticals sector.
Financial Metrics
Revenue
2026-06-30
$0
2026-03-31
$0
2025-12-31
$0
2025-09-30
$0
Operating Expenses
2026-06-30
$5.54M
2026-03-31
$5.13M
2025-12-31
$4.52M
2025-09-30
$4.01M
Net Income
2026-06-30
-$5.46M
2026-03-31
-$4.99M
2025-12-31
-$4.34M
2025-09-30
-$3.94M
Net Profit Margin
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
Earnings Per Share
2026-06-30
$-1.90
2026-03-31
$-1.77
2025-12-31
$-1.74
2025-09-30
$-6.70
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$5.54M
2026-03-31
-$5.09M
2025-12-31
-$4.32M
2025-09-30
-$3.92M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Operating Expenses | $5.54M | $5.13M | $4.52M | $4.01M |
| Net Income | -$5.46M | -$4.99M | -$4.34M | -$3.94M |
| Net Profit Margin | -- | -- | -- | -- |
| Earnings Per Share | $-1.90 | $-1.77 | $-1.74 | $-6.70 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$5.54M | -$5.09M | -$4.32M | -$3.92M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.